Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multi-center, Randomized, No-treatment Controlled, Evaluator-blinded, Superiority Clinical Trial to Evaluate the Safety and Effectiveness of Sodium Hyaluronate 32 mg/ml for Improvement of Facial Skin Dryness and Dullness

NCT06914583 is registered in ClinicalTrials.gov with IBSA Farmaceutici Italia Srl as lead sponsor.

NCT NCT06914583
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06914583 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multi-center, Randomized, No-treatment Controlled, Evaluator-blinded, Superiority Clinical Trial to Evaluate the Safety and Effectiveness of Sodium Hyaluronate 32 mg/ml for Improvement of Facial Skin Dryness and Dullness
Lead sponsor
IBSA Farmaceutici Italia Srl
Phase
Not applicable
Overall status
Recruiting
Start date
February 19, 2025
Completion date
February 28, 2026
Enrollment
500 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

facial dryness, facial dullness